Eric Goosby, MD
Member, Biden-Harris Transition COVID-19 Advisory Board
Professor of Medicine and Director of Global Health Delivery, Diplomacy and Economics, Institute for Global Health Sciences, University of California, San Francisco
Former UN Special Envoy on Tuberculosis
Dr. Eric Goosby is a Professor of Medicine and Director of Global Health Delivery and Diplomacy, Institute for Global Health Sciences, at the University of California, San Francisco. In Jan. 2015, Dr. Goosby was appointed the UN Special Envoy on Tuberculosis (TB). He was central in the planning and implementation of the UN General Assembly High Level Meeting on TB in Sept. 2018 and serving as lead editor on the Lancet Commission on TB.
During the Obama Administration, Dr. Goosby served as Ambassador-at-Large and U.S. Global AIDS Coordinator, overseeing the implementation of PEPFAR, and founded the State Department’s Office of Global Health Diplomacy. As CEO and Chief Medical Officer of Pangaea Global AIDS Foundation, he played a key role in the development and implementation of HIV/AIDS national treatment scale-up plans in South Africa, Rwanda, China and Ukraine. Previously, Dr. Goosby was Director of the Ryan White Care Act at the U.S. Dept. of Health and Human Services (HHS), and later, Deputy Director of the White House National AIDS Policy Office and Director of the Office of HIV/AIDS Policy at HHS where he created and chaired the Guidelines for Antiretroviral Therapy for Adults, Adolescents, and Pregnant Women.
Dr. Goosby is a member of the National Academy of Medicine and the Council on Foreign Relations. He is Board Chair of the International AIDS Vaccine Initiative, and an Advisor to the Director of NIH, Fogarty International NIH, the Clinton Foundation, Elton John Foundation and on Advisory/Guideline Boards for UNAIDS, WHO TB office and WHO HIV office. He is an advisor to the UK Antimicrobial Resistance Initiative and to numerous Government Ministries of Health and Schools of Public Health globally.
Twitter: @DrEricGoosby